Statements (18)
Predicate | Object |
---|---|
gptkbp:instanceOf |
phosphate binder
|
gptkbp:activeIngredient |
gptkb:sucroferric_oxyhydroxide
|
gptkbp:approvedBy |
gptkb:FDA
2013 |
gptkbp:ATCCode |
gptkb:V03AE05
|
gptkbp:form |
chewable tablet
|
https://www.w3.org/2000/01/rdf-schema#label |
Velphoro
|
gptkbp:manufacturer |
gptkb:Fresenius_Medical_Care
|
gptkbp:marketedIn |
gptkb:Europe
gptkb:United_States |
gptkbp:prescriptionStatus |
prescription only
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
nausea
diarrhea discolored feces |
gptkbp:usedFor |
hyperphosphatemia in chronic kidney disease
|
gptkbp:bfsParent |
gptkb:Vifor_Pharma
|
gptkbp:bfsLayer |
7
|